Apyx Medical Co. (NASDAQ:APYX) Shares Bought by AIGH Capital Management LLC

AIGH Capital Management LLC raised its position in Apyx Medical Co. (NASDAQ:APYXFree Report) by 7.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,040,540 shares of the company’s stock after acquiring an additional 145,309 shares during the quarter. Apyx Medical comprises approximately 2.1% of AIGH Capital Management LLC’s holdings, making the stock its 18th largest position. AIGH Capital Management LLC owned approximately 0.06% of Apyx Medical worth $5,346,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Kingsview Wealth Management LLC acquired a new position in Apyx Medical in the 4th quarter valued at about $32,000. ProVise Management Group LLC acquired a new position in Apyx Medical in the 4th quarter valued at about $35,000. Barclays PLC acquired a new position in Apyx Medical in the 3rd quarter valued at about $46,000. Jump Financial LLC acquired a new position in Apyx Medical in the 3rd quarter valued at about $48,000. Finally, Algert Global LLC acquired a new position in Apyx Medical in the 3rd quarter valued at about $50,000. 55.33% of the stock is owned by institutional investors and hedge funds.

Apyx Medical Price Performance

NASDAQ APYX remained flat at $1.60 during trading on Monday. The company’s stock had a trading volume of 9,100 shares, compared to its average volume of 131,531. The company has a market capitalization of $55.42 million, a P/E ratio of -2.42 and a beta of 1.10. The company has a debt-to-equity ratio of 1.64, a current ratio of 5.87 and a quick ratio of 4.94. The business’s fifty day moving average is $1.46 and its 200 day moving average is $1.98. Apyx Medical Co. has a 52 week low of $1.21 and a 52 week high of $7.97.

Apyx Medical (NASDAQ:APYXGet Free Report) last announced its quarterly earnings data on Thursday, May 9th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.04). Apyx Medical had a negative return on equity of 76.16% and a negative net margin of 45.20%. The company had revenue of $10.24 million for the quarter, compared to analyst estimates of $9.64 million. During the same period in the prior year, the firm posted ($0.10) earnings per share. On average, sell-side analysts anticipate that Apyx Medical Co. will post -0.75 earnings per share for the current year.

Apyx Medical Profile

(Free Report)

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.

Further Reading

Want to see what other hedge funds are holding APYX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Apyx Medical Co. (NASDAQ:APYXFree Report).

Institutional Ownership by Quarter for Apyx Medical (NASDAQ:APYX)

Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.